These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. [Thesaurus of pharmacist interventions associated with inappropriate proton pump inhibitors prescriptions]. Veremme L; Baudouin A; Janoly-Dumenil A; Charpiat B Ann Pharm Fr; 2023 May; 81(3):552-567. PubMed ID: 36375534 [TBL] [Abstract][Full Text] [Related]
43. Proton pump inhibitors and acute interstitial nephritis: report and analysis of 15 cases. Simpson IJ; Marshall MR; Pilmore H; Manley P; Williams L; Thein H; Voss D Nephrology (Carlton); 2006 Oct; 11(5):381-5. PubMed ID: 17014549 [TBL] [Abstract][Full Text] [Related]
44. Proton Pump Inhibitors and Kidney Disease: Fact or Fiction? Weir MR Am J Nephrol; 2024; 55(4):499-508. PubMed ID: 38583423 [TBL] [Abstract][Full Text] [Related]
45. Community-dwelling older adults' awareness of the inappropriate use of proton pump inhibitors. Rababa M; Rababa'h A BMC Geriatr; 2020 Oct; 20(1):431. PubMed ID: 33121444 [TBL] [Abstract][Full Text] [Related]
46. Use of Proton Pump Inhibitors and the Risk of Acute Kidney Injury Among Patients with Rheumatoid Arthritis: Cohort Study. Svanström H; Lund M; Melbye M; Pasternak B Drug Saf; 2018 Aug; 41(8):817-826. PubMed ID: 29603109 [TBL] [Abstract][Full Text] [Related]
47. Proton Pump Inhibitors Augment the Risk of Major Adverse Cardiovascular Events and End-Stage Renal Disease in Patients With Acute Kidney Injury After Temporary Dialysis. Tsai IJ; Lai TS; Shiao CC; Huang TM; Wang CH; Tsao CH; Chen LW; Lin YH; Chen L; Wu VC; Chu TS; Clin Pharmacol Ther; 2020 Jun; 107(6):1434-1445. PubMed ID: 31901200 [TBL] [Abstract][Full Text] [Related]
48. The use of proton pump inhibitors in an Italian hospital: focus on oncologic and critical non-ICU patients. Meli M; Raffa MP; Malta R; Morreale I; Aprea L; D'Alessandro N Int J Clin Pharm; 2015 Dec; 37(6):1152-61. PubMed ID: 26319396 [TBL] [Abstract][Full Text] [Related]
49. Is there overuse of proton pump inhibitors in B-cell non-Hodgkin lymphomas? A cohort study based on the French health insurance database in the Midi-Pyrénées region. Conte C; Bourrel R; Despas F; Lapeyre-Mestre M Fundam Clin Pharmacol; 2019 Jun; 33(3):327-338. PubMed ID: 30625254 [TBL] [Abstract][Full Text] [Related]
50. Drug rash with eosinophilia and systemic symptoms and severe renal injury induced by proton pump inhibitor therapy: A case report. He Q; Ying G; Fei X; Zha C; Chen Z; Bao Y; Long J; Wang Z; He X; Xia M Medicine (Baltimore); 2020 Oct; 99(42):e22509. PubMed ID: 33080685 [TBL] [Abstract][Full Text] [Related]
51. Chronic use of proton pump inhibitors, adverse events and potential biological mechanisms: A translational analysis. Kheloufi F; Frankel D; Kaspi E; Lepelley M; Mallaret M; Boucherie Q; Roll P; Micallef J Therapie; 2018; 73(3):273-281. PubMed ID: 29128115 [TBL] [Abstract][Full Text] [Related]
52. Adverse outcomes of proton pump inhibitors in chronic liver disease: a systematic review and meta-analysis. Wang J; Wu Y; Bi Q; Zheng X; Zhang J; Huang W Hepatol Int; 2020 May; 14(3):385-398. PubMed ID: 31912308 [TBL] [Abstract][Full Text] [Related]
53. [Prospective study of drug-induced interstitial nephritis in eleven French nephrology units]. Leven C; Hudier L; Picard S; Longuet H; Lorcy N; Cam G; Boukerroucha Z; Dolley-Hitze T; Le Cacheux P; Halimi JM; Cornec Le Gall E; Hanrotel-Saliou C; Arreule A; Massad M; Duveau A; Couvrat-Desvergnes G; Renaudineau E Presse Med; 2014 Nov; 43(11):e369-76. PubMed ID: 25218248 [TBL] [Abstract][Full Text] [Related]
60. A benefit-risk assessment of the use of proton pump inhibitors in the elderly. Masclee GM; Sturkenboom MC; Kuipers EJ Drugs Aging; 2014 Apr; 31(4):263-82. PubMed ID: 24634248 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]